Do patients with major depressive disorder and generalized anxiety disorder experience more somatosensorial amplification, hypochondriasis, and fear of COVID-19?
DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, cilt.35, sa.1, ss.34-42, 2022 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 35 Sayı: 1
- Basım Tarihi: 2022
- Doi Numarası: 10.14744/dajpns.2022.00169
- Dergi Adı: DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Psycinfo, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.34-42
- Anahtar Kelimeler: Anxiety, COVID-19, depression, hypochondriasis, somatosensorial amplification, MENTAL-HEALTH, SOMATIZATION, POPULATION, SYMPTOMS, LOCKDOWN, PEOPLE, IMPACT, SCALE
- Süleyman Demirel Üniversitesi Adresli: Evet
Özet
Objective: Mental illnesses are important determinants in response to the pandemic. However, there are only a limited number of studies investigating the effects of COVID-19 in individuals with mental illnesses. We aimed to reveal the fear of COVID-19, somatosensorial amplification levels, anxiety, depression, and stress levels of patients with major depressive disorder (MDD) and generalized anxiety disorder (GAD).